Detalhe da pesquisa
1.
Serpins promote cancer cell survival and vascular co-option in brain metastasis.
Cell;
156(5): 1002-16, 2014 Feb 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24581498
2.
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature;
596(7870): 126-132, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34290408
3.
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
N Engl J Med;
389(6): 491-503, 2023 Aug 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37272513
4.
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors.
Cancer Immunol Immunother;
71(10): 2405-2420, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35217892
5.
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature;
598(7881): E1, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34608287
6.
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
N Engl J Med;
378(21): 1976-1986, 2018 May 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29658848
7.
Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA.
Future Oncol;
17(31): 4045-4055, 2021 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34278827
8.
YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.
Proc Natl Acad Sci U S A;
115(26): E6030-E6038, 2018 06 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29875142
9.
Adrenal Metastasectomy in the Presence and Absence of Extraadrenal Metastatic Disease.
Ann Surg;
270(2): 373-377, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29578911
10.
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.
Lancet Oncol;
17(3): 299-308, 2016 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26858122
11.
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
N Engl J Med;
379(9): e14, 2018 08 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30157404
12.
Neoadjuvant and adjuvant approaches in surgically resectable NSCLC.
Clin Adv Hematol Oncol;
19(10): 631-633, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34637428
13.
Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint.
Lancet Oncol;
15(1): e42-50, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24384493
14.
Pathologic response in resectable non-small cell lung cancer: a systematic literature review and meta-analysis.
JNCI Cancer Spectr;
2024 Mar 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38521542
15.
An 18F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy.
J Nucl Med;
65(4): 520-526, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38485270
16.
The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.
Ann Thorac Surg;
2024 Feb 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38316378
17.
Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma.
J Thorac Oncol;
19(5): 829-838, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38154515
18.
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.
Cancer Immunol Res;
12(3): 308-321, 2024 03 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38108398
19.
Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.
Mod Pathol;
26(4): 511-22, 2013 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23196793
20.
Early-stage anaplastic lymphoma kinase (ALK)-positive lung cancer: a narrative review.
Transl Lung Cancer Res;
12(2): 337-345, 2023 Feb 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36895922